Jefferies Group LLC Iveric Bio, Inc. Call Options Transaction History

Jefferies Group LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Sep 21, 2023	BUY	$9.4 - $18.59 $343,100 - $678,535	36,500 Added 1042.86%	40,000 $717,000
Q3 2022 Nov 14, 2022	BUY	$9.4 - $18.59 $343,100 - $678,535	36,500 Added 1042.86%	40,000 $718,000
Q2 2022 Sep 21, 2023	SELL	$9.12 - $18.9 $355,679 - $737,100	-39,000 Reduced 91.76%	3,500 $33,000
Q2 2022 Aug 15, 2022	SELL	$9.12 - $18.9 $355,679 - $737,100	-39,000 Reduced 91.76%	3,500 $34,000
Q1 2022 Sep 21, 2023	BUY	$12.15 - $16.83 $30,375 - $42,074	2,500 Added 6.25%	42,500 $715,000

Q1 2022 May 16, 2022	BUY	$12.15 - $16.83 $516,375 - $715,274	42,500 New	42,500 $715,000

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.